Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02027935
What this trial is testing

CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
M.D. Anderson Cancer Center 16
Early research (Phase 1)Looking for participantsNCT07192900
What this trial is testing

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

Who this might be right for
Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more
David Bartlett, MD 10
Testing effectiveness (Phase 2)Looking for participantsNCT02621021
What this trial is testing

Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

Who this might be right for
Melanoma
National Cancer Institute (NCI) 53
Early research (Phase 1)Temporarily pausedNCT03970382
What this trial is testing

Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
PACT Pharma, Inc. 21
Early research (Phase 1)UnknownNCT03258359
What this trial is testing

Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)

Who this might be right for
Myelodysplastic Syndromes
PersImmune, Inc 12
Testing effectiveness (Phase 2)Looking for participantsNCT06552169
What this trial is testing

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Who this might be right for
Kidney Transplantation
Singulera Therapeutics Inc. 34
Testing effectiveness (Phase 2)UnknownNCT00048464
What this trial is testing

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Who this might be right for
Multiple Myeloma
Xcyte Therapies 35
Testing effectiveness (Phase 2)Study completedNCT00553306
What this trial is testing

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Fred Hutchinson Cancer Center 10
Early research (Phase 1)Study completedNCT02315612
What this trial is testing

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

Who this might be right for
NHLLarge Cell LymphomaFollicular Lymphoma+7 more
National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT03272334
What this trial is testing

Her2-BATS and Pembrolizumab in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Virginia 22
Testing effectiveness (Phase 2)Ended earlyNCT05972720
What this trial is testing

Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

Who this might be right for
CancerRelapsed/Refractory Large B-cell Lymphoma (LBCL)
CARGO Therapeutics 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT00338377
What this trial is testing

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 1,230